The results showed that circulating FGF21 levels were positively associated with the prevalence of CAD in men with T2DM, after adjusting for all potential confounders in this study, whereas serum testosterone concentrations were negatively associated with the prevalence of CAD in men with T2DM, indicating an L-shaped association. The gene discussed is FGF21; the disease is coronary artery disorder.